The Mother & Baby Substance Exposure Initiative, part of the Medication Assisted Treatment Expansion Project, is a hospital and community-based effort to improve outcomes for mothers and newborns impacted by substance exposure, with a specific focus on Opioid Use Disorder.
CPQCC and CMQCC are jointly implementing this project in collaboration with Health Management Associates (HMA). The Mother & Baby Substance Exposure Initiative is funded by the California Department of Health Care Services (DHCS) as part of a Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response grant.
The Mother & Baby Substance Exposure Initiative will emphasize care that maintains the mother-baby dyad throughout the hospital stay and will also address treatment and prevention of substance exposure during and after pregnancy.
Key components of this initiative include:
- Leading a multidisciplinary taskforce of experts from across California to develop a toolkit for maternal and newborn care providers on perinatal substance exposure, with a focus on opioid exposure
- Implementing quality improvement collaboratives for hospitals in selected counties across Northern, Central and Southern California
- Collecting and reporting data to support quality improvement
- Mobilizing and supporting public and private partners across the state
- Networking and learning from other states that have implemented the Alliance for Innovation on Maternal Health (AIM) National Collaborative Opioid Bundle
The Mother & Baby Substance Exposure Initiative is funded from January 2019 through September 2020
